Comments
Loading...

Inozyme Pharma

INZYNASDAQ
Logo brought to you by Benzinga Data
$4.02
-0.08-1.95%
At close: -
$4.05
0.030.75%
After Hours: 5:52 PM EDT
Q3 2024 Earnings were released on Tue Nov 5th, before the market open

Inozyme Pharma (NASDAQ:INZY) Stock, Earnings Estimates, EPS, And Revenue

Inozyme Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 5
EPS
$-0.390
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Inozyme Pharma using advanced sorting and filters.

Data brought to you by Benzinga APIs

Inozyme Pharma (INZY) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-05$-0.39$-0.4411.4 %
Jun 20242024-08-06$-0.44$-0.39-12.8 %
Mar 20242024-05-07$-0.38$-0.36-5.56 %
Dec 20232024-03-12$-0.33$-0.32-3.12 %

Inozyme Pharma (INZY) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Inozyme Pharma (NASDAQ:INZY) reporting earnings?

A

Inozyme Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Inozyme Pharma (NASDAQ:INZY)?

A

Inozyme Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was $-0.39, which beat the estimate of $-0.44.

Q

What were Inozyme Pharma’s (NASDAQ:INZY) revenues?

A

Inozyme Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch